相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
Chiya Oshiro et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
Jean Sebastien Frenel et al.
CLINICAL CANCER RESEARCH (2015)
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach
Jelena Belic et al.
CLINICAL CHEMISTRY (2015)
Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor-Positive Metastatic Breast Cancer
David S. Guttery et al.
CLINICAL CHEMISTRY (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau et al.
LANCET ONCOLOGY (2015)
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy R. Yates et al.
NATURE MEDICINE (2015)
Circulating tumor-derived DNA is shorter than somatic DNA in plasma
Florent Mouliere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
Gaia Schiavon et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
Muhammed Murtaza et al.
NATURE COMMUNICATIONS (2015)
Actionable Mutations in Plasma Cell-Free DNA in Patients with Advanced Cancers Referred for Experimental Targeted Therapies
Filip Janku et al.
ONCOTARGET (2015)
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
Frederic Amant et al.
JAMA ONCOLOGY (2015)
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
Jordan Madic et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2014)
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F. Rothe et al.
ANNALS OF ONCOLOGY (2014)
Personalized treatments of cancer patients: A reality in daily practice, a costly dream or a shared vision of the future from the oncology community?
Monica Arnedos et al.
CANCER TREATMENT REVIEWS (2014)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
Fabrice Andre et al.
LANCET ONCOLOGY (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Hematogenous dissemination of glioblastoma multiforme
Carolin Mueller et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
James P. Sullivan et al.
CANCER DISCOVERY (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
The dynamic range of circulating tumor DNA in metastatic breast cancer
Maryam Heidary et al.
BREAST CANCER RESEARCH (2014)
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
H. Raza Ali et al.
GENOME BIOLOGY (2014)
D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
Keren Merenbakh-Lamin et al.
CANCER RESEARCH (2013)
Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
Heidrun Gevensleben et al.
CLINICAL CANCER RESEARCH (2013)
A new genome-driven integrated classification of breast cancer and its implications
Sarah-Jane Dawson et al.
EMBO JOURNAL (2013)
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
Ellen Heitzer et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
The shaping and functional consequences of the microRNA landscape in breast cancer
Heidi Dvinge et al.
NATURE (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
Leticia De Mattos-Arruda et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Implementing personalized cancer genomics in clinical trials
Richard Simon et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Implications of Clonal Genome Evolution for Cancer Medicine
Samuel Aparicio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pilot Studies for Personalized Cancer Medicine: Focusing on the Patient for Treatment Selection
Leticia De Mattos-Arruda et al.
ONCOLOGIST (2013)
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
Walter W. Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells
Jiajun Cui et al.
CANCER RESEARCH (2012)
Med1 plays a critical role in the development of tamoxifen resistance
Arumugam Nagalingam et al.
CARCINOGENESIS (2012)
The Life History of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Michaela J. Higgins et al.
CLINICAL CANCER RESEARCH (2012)
Molecular Profiling of Patients with Colorectal Cancer and Matched Targeted Therapy in Phase I Clinical Trials
Rodrigo Dienstmann et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Ruth E. Board et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Use of Cancer-Specific Genomic Rearrangements to Quantify Disease Burden in Plasma from Patients with Solid Tumors
David J. McBride et al.
GENES CHROMOSOMES & CANCER (2010)
Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
Iris Lavon et al.
NEURO-ONCOLOGY (2010)
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
Li Liu et al.
CANCER RESEARCH (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
Zhenbin Chen et al.
PLOS ONE (2009)
分享论文
